Cresco Labs falls just shy of revenue target

Cresco Labs Inc. /zigman2/quotes/200392306/delayed CRLBF -1.08% /zigman2/quotes/205276242/delayed CA:CL +0.43% said Wednesday its second-quarter loss increased to $8.3 million from $2.65 million in the year-ago period. The company did not provide a loss per share figure. Second-quarter revenue increased by 4% to $218.2 million from $210 million. Wall Street analysts were expecting Cresco Labs to generate revenue of $218.3 million, according to a FactSet survey. Cresco Labs co-founder and CEO Charles Bachtell said the company reported "solid results in the face of an unprecedented macro environment." Cresco Labs is holding and growing market share, focusing on efficiencies across the business to maintain margins, and preparing for its acquisition of Columbia Care, he said. Shares of Cresco Labs are down 43.8% in 2022 compared to a loss of 52.5% by the AdvisorShares Pure US Cannabis ETF /zigman2/quotes/220307682/composite MSOS +0.59% and a loss of 16.3% by the Nasdaq /zigman2/quotes/210598365/realtime COMP -0.23% .

/zigman2/quotes/200392306/delayed

Add to watchlist CRLBF

Cresco Labs Inc.

US : U.S.: OTC

$ 1.70

-0.02 -1.08%

Volume: 312,988

Nov. 30, 2023 3:58p

P/E Ratio

N/A

Dividend Yield

N/A

Market Cap

$743.55 million

Rev. per Employee

$244,446

/zigman2/quotes/205276242/delayed

Add to watchlist CA:CL

Cresco Labs Inc.

CA : Canadian Securities Exchange

$ 2.31

+0.01 +0.43%

Volume: 102,019

Nov. 30, 2023 3:58p

P/E Ratio

N/A

Dividend Yield

N/A

Market Cap

$1.01 billion

Rev. per Employee

$329,682

/zigman2/quotes/220307682/composite

Add to watchlist MSOS

AdvisorShares Pure US Cannabis ETF

US : U.S.: NYSE Arca

$ 6.82

+0.04 +0.59%

Volume: 2.93M

Nov. 30, 2023 4:00p

/zigman2/quotes/210598365/realtime

Add to watchlist COMP

NASDAQ Composite Index

US : Nasdaq

14,226.22

-32.27 -0.23%

Volume: 5.77B

Nov. 30, 2023 5:16p